Metals X Limited (MLXEF) Fair Value & Analysis
Basic Materials · US · Market cap $883M
Fair value as of: Jul 17, 2026
From 26 valuation models · updated 6 days ago
Share price +0.5% over the past month.
Price vs Fair Value (12 months)
12‑month range $0.3410 – $1.22 · fair‑value band $0.5028 – $1.35 · the $0.9950 price screens above the $0.6704 fair value. As of Jul 17, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Metals X Limited (MLXEF) currently trades at $0.9950, while our model-based Fair Value estimate is $0.6704, implying the stock looks roughly 32.6% overvalued today. We read business quality at 69/100 (solid quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).
Over the trailing twelve months, Metals X Limited generated revenue of $285M at a net margin of 36.7%. Revenue grew 11.0% year over year. It earns a return on equity of 21.8%. The balance sheet holds a net cash position of $290M. Fundamentals as of Jul 17, 2026
Our scenario range runs from $0.5028 (bear case) to $1.35 (bull case); at $0.9950, the current price sits within that range. The share trades about 20% below its 52-week high and 192% above its 52-week low, currently above its 200-day average. For context, the median of 10 Basic Materials peers we cover trades at -27% fair-value upside, at -33%, MLXEF screens richer than that median.
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 17, 2026. TTM = trailing twelve months.
About the company
Metals X Limited engages in the production of tin in Australia. The company holds a 50% interest in the Renison tin project located on the Northwest Tasmania. It offers tin-in-concentrate, as well as invests in companies undertaking exploration and development of tin, gold, and base metals projects. Metals X Limited was incorporated in 2004 and is based in South Perth, Australia.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Metals X Limited reported revenue of $285M in FY2025 versus $229M in FY2021, a compound +5.6%/yr. Reported net income was $105M in FY2025, compounding −13.2%/yr from FY2021.
Is MLXEF fairly valued? → Check now
Similar stocks
10 more Other Industrial Metals & Mining stocks, each showing price versus our Fair Value estimate (as of Jul 17, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| BHP Group BHPLF | $41.19 | $30.11 | -27% |
| Rio Tinto Group RTNTF | $129.57 | $76.59 | -41% |
| Grupo México, S.A. GMBXF | $12.66 | $9.58 | -24% |
| CMOC Group CMCLY | $148.88 | $120.33 | -19% |
| Vale S.A VALE | $15.71 | $7.88 | -50% |
| Anglo American plc AAUKF | $51.51 | $20.30 | -61% |
| Fortescue Ltd FSUMF | $14.80 | $15.72 | +6% |
| China Tungsten And Hightech Materials Co 000657 | ¥74.71 | ¥9.55 | -87% |
| Hindustan Zinc Limited HINDZINC | ₹547.55 | ₹625.07 | +14% |
| China Northern Rare Earth (Group) High-Tech Co 600111 | ¥47.11 | ¥6.74 | -86% |
Explore undervalued stocks
More undervalued Basic Materials stocks →
Frequently asked questions
Is Metals X Limited (MLXEF) undervalued?
What is the fair value of MLXEF?
What is the quality score of MLXEF?
What is the revenue of Metals X Limited (MLXEF)?
What is the net profit margin of MLXEF?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Unlock the full Metals X Limited analysis, and try Pro free
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.
Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.